BELROSE PHARMA INC has a total of 19 patent applications. Its first patent ever was published in 2003. It filed its patents most often in EPO (European Patent Office), United States and Canada. Its main competitors in its focus markets pharmaceuticals, biotechnology and macromolecular chemistry and polymers are KEYBIOSCIENCE AG, PHASEBIO PHARMACEUTICALS INC and RHYTHM METABOLIC INC.
# | Country | Total Patents | |
---|---|---|---|
#1 | EPO (European Patent Office) | 12 | |
#2 | United States | 4 | |
#3 | Canada | 3 |
# | Name | Total Patents |
---|---|---|
#1 | Zhao Hong | 18 |
#2 | Yang Karen | 9 |
#3 | Reddy Prasanna | 3 |
#4 | Xia Jing | 2 |
#5 | Rubio Maria Belen | 2 |
#6 | Shi Lianjun | 1 |
#7 | Pastorino Fabio | 1 |
#8 | Ponzoni Mirco | 1 |
#9 | Wu Dechun | 1 |
#10 | Pendri Annapurna | 1 |
Publication | Filing date | Title |
---|---|---|
US2014039158A1 | Polymeric conjugates and methods of preparing the same | |
EP2304026A2 | Nanoparticle compositions for nucleic acids delivery system | |
EP2176404A1 | Polymeric drug delivery systems containing an aromatic allylic acid | |
EP2073820A2 | Targeted polymeric prodrugs containing multifunctional linkers |